Vinorelbine (VNR) by alternating intravenous (IV)/oral administration plus cisplatinum (CP) followed by oral VNR as first-line therapy of advanced non-small cell lung cancer (ANSCLC)

被引：0
|
作者：
Sperandi, Francesca
Melotti, Barbara
Giaquinta, Stefania
Piana, Edera
Pavesi, Lorenzo
Da Prada, Gian Antonio
Lelli, Giorgio
Martoni, Andrea Angelo
机构：
[1] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy
[2] S Maugeri Fdn, Pavia, Italy
[3] Arcispedale St Anna, Ferrara, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [21] A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
    Lerouge, Delphine
    Riviere, Alain
    Dansin, Eric
    Chouaid, Christos
    Dujon, Cecile
    Schott, Roland
    Lavole, Armelle
    Le Pennec, Vincent
    Fabre, Elizabeth
    Crequit, Jacky
    Martin, Francis
    Dehette, Stephanie
    Fournel, Pierre
    Precheur-Agulhon, Benedicte
    Lartigau, Eric
    Zalcman, Gerard
    BMC CANCER, 2014, 14
  • [22] Vinorelbine (VNR)-cisplatin (CDDP)-carboplatin (CBDCA) combination in locally advanced or metastatic non-small cell lung cancer (NSCLC) plus phase II study
    Zylberait, D
    Charvolin, P
    Bernabeu, L
    Dumont, P
    Fallouh, H
    Biville, F
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 98
  • [23] A pilot-study with gemcitabine (GEM), vinorelbine (VNR) and cisplatin (P) in the treatment of advanced non-small cell lung cancer (NSCLC).
    Laack, E
    Mende, T
    Dürk, H
    Kneba, M
    Dickgreber, N
    Müller, T
    Scholtze, J
    Graeven, U
    Hirth, M
    Hossfeld, DK
    ANNALS OF ONCOLOGY, 2000, 11 : 115 - 115
  • [24] Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II study
    O'Brien, MER
    Szczesna, A
    Karnicka, H
    Zatloukal, P
    Eisen, T
    Hartmann, W
    Kasan, P
    Longerey, B
    Lefresne, F
    ANNALS OF ONCOLOGY, 2004, 15 (06) : 921 - 927
  • [25] Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma
    Vallejo, C
    Romero, A
    Perez, J
    Cuevas, M
    Lacava, J
    Sabatini, C
    Dominguez, M
    Rodriguez, R
    Barbieri, M
    Acuna, LR
    Acuna, JR
    Langhi, M
    Amato, S
    Salvadori, M
    Ortiz, E
    Machiavelli, M
    Leone, B
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (06): : 584 - 588
  • [26] Oral vinorelbine in combination with carboplatin followed by maintenance therapy with oral vinorelbine concurrent with radiotherapy in locally advanced non small cell lung cancer.
    El-Sadda, Wael
    Halim, Inas Ibraheim Abdel
    Magdy, Mona
    El-Ebrashy, Mostafa
    Daghriri, Hassan Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study
    D Serin
    M Verrill
    A Jones
    T Delozier
    R Coleman
    E-D Kreuser
    K Mross
    B Longerey
    M Brandely
    British Journal of Cancer, 2005, 92 : 1989 - 1996
  • [28] Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study
    Serin, D
    Verrill, M
    Jones, A
    Delozier, T
    Coleman, R
    Kreuser, ED
    Mross, K
    Longerey, B
    Brandely, M
    BRITISH JOURNAL OF CANCER, 2005, 92 (11) : 1989 - 1996
  • [29] A multicenter phase II trial with gemcitabine (GEM) and vinorelbine (VNR) in the treatment of non-small cell lung cancer (NSCLC) stage IIIB and IV
    Laack, E
    Mende, T
    Saal, JG
    Chemaissani, A
    Scholtze, J
    Lorenz, C
    Dalhoff, K
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S252 - S252
  • [30] EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
    Fong, Thomas
    Morgensztern, Daniel
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (03) : 303 - 310
12345